Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK.
Cell Rep. 2013 Jan 31;3(1):246-59. doi: 10.1016/j.celrep.2012.12.008. Epub 2013 Jan 10.
The genome of a cancer cell carries somatic mutations that are the cumulative consequences of the DNA damage and repair processes operative during the cellular lineage between the fertilized egg and the cancer cell. Remarkably, these mutational processes are poorly characterized. Global sequencing initiatives are yielding catalogs of somatic mutations from thousands of cancers, thus providing the unique opportunity to decipher the signatures of mutational processes operative in human cancer. However, until now there have been no theoretical models describing the signatures of mutational processes operative in cancer genomes and no systematic computational approaches are available to decipher these mutational signatures. Here, by modeling mutational processes as a blind source separation problem, we introduce a computational framework that effectively addresses these questions. Our approach provides a basis for characterizing mutational signatures from cancer-derived somatic mutational catalogs, paving the way to insights into the pathogenetic mechanism underlying all cancers.
癌细胞的基因组携带体细胞突变,这些突变是从受精卵到癌细胞这一细胞谱系中 DNA 损伤和修复过程的累积结果。值得注意的是,这些突变过程的特征描述还很差。全球测序计划正在从数千种癌症中产生体细胞突变目录,从而为破译在人类癌症中起作用的突变过程特征提供了独特的机会。然而,到目前为止,还没有描述癌症基因组中起作用的突变过程特征的理论模型,也没有系统的计算方法来破译这些突变特征。在这里,我们通过将突变过程建模为盲源分离问题,引入了一种计算框架,有效地解决了这些问题。我们的方法为从癌症衍生的体细胞突变目录中描述突变特征提供了基础,为深入了解所有癌症的发病机制铺平了道路。